Clinical Trial Update: Induction Chemotherapy Combined With Tislelizumab for Locally Advanced Squamous Cell Carcinoma of the External Auditory Canal [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating induction chemotherapy combined with Tislelizumab for locally advanced squamous cell carcinoma of the external auditory canal …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Squamous Cell Carcinoma of External Auditory Canal

Drugs mentioned

• Tislelizumab (tislelizumab)

Snippet

Sponsor: Eye & ENT Hospital of Fudan University | Conditions: Squamous Cell Carcinoma of External Auditory Canal, Locally Advanced Tumor | Phase 2 | Status: RECRUITING